FDA Releases Draft Guidance to Reduce Creutzfeldt-Jakob Disease Transmission via Blood and Blood Components

Summary

The FDA has published a draft guidance to provide blood establishments with revised recommendations to minimize the risk of transmitting Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease through blood and blood components, replacing a 2017 document and expected to supersede another document upon finalization.